Toxicities associated with immune checkpoint inhibitors: a systematic study

Available evidence shows that the incidence of toxicities associated with cancer immunotherapy, such as programmed cell death 1 (PD-1) and programmed cell death 1 ligand 1 (PD-L1)-related toxicities, is estimated to be between 0.3 and 1.3%. OBJECTIVE: This systematic review aimed to investigate canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiangyi, Chen, Li, Su, Zhaohui, Sullivan, Ryan J., Blum, Steven M., Qi, Zhihong, Liu, Yulu, Huo, Yujia, Fang, Yi, Zhang, Lin, Gao, Jidong, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389211/
https://www.ncbi.nlm.nih.gov/pubmed/37132038
http://dx.doi.org/10.1097/JS9.0000000000000368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389211/
https://www.ncbi.nlm.nih.gov/pubmed/37132038
http://dx.doi.org/10.1097/JS9.0000000000000368

Ejemplares similares